Clare Y. Slaney
Parkville, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Ironing out a metabolic barrier to durable CAR T cell therapy.
Journal: Cell research
Published: July 30, 2026
Parallel processing of T cells and natural killer cells to enhance in vivoCAR T cell activity against blood and solid cancers.
Journal: Clinical & translational immunology
Published: December 12, 2025
Rewiring immunity with in vivo CAR T cell engineering.
Journal: Nature cancer
Published: December 04, 2025
Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft models.
Journal: Science translational medicine
Published: October 29, 2025
Optimised modular anti-FLAG CAR T cells for solid tumor therapy.
Journal: Clinical & translational immunology
Published: March 26, 2025
Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals.
Journal: Clinical & translational immunology
Published: January 10, 2024
TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models.
Journal: Science translational medicine
Published: April 05, 2023
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy.
Journal: Nature
Published: February 13, 2023
Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges.
Journal: Cancers
Published: February 01, 2023
Editorial: Combining chemo/radio therapy and immunotherapy for cancers-perfect mix of old and new.
Journal: Frontiers in immunology
Published: December 22, 2022
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells.
Journal: Nature communications
Published: May 25, 2022
Last Updated: 09/26/2026